# Assessment of Depression and Anxiety in Hemodialysis Patients Undergoing VR Therapy—Pilot Study

**Authors:** Łukasz Rogowski, Mariusz Kusztal, Joanna Kowalska, Małgorzata Stefańska, Agnieszka Zembroń-Łacny, Tomasz Gołębiowski, Wioletta Dziubek

PMC · DOI: 10.3390/jcm15041489 · 2026-02-13

## TL;DR

This pilot study found that using virtual reality during hemodialysis can reduce anxiety and depression while improving life satisfaction and self-efficacy in patients with kidney failure.

## Contribution

The study is one of the first to explore the psychological benefits of VR therapy specifically for hemodialysis patients.

## Key findings

- VR therapy significantly reduced anxiety and depression in hemodialysis patients.
- Patients reported increased life satisfaction and self-efficacy after VR sessions.
- VR therapy showed psychological benefits compared to a control group without VR.

## Abstract

Background/Objectives: Patients with end-stage renal disease (ESRD) are at a significant risk for depressive and anxiety disorders, including severe depression. The use of virtual reality (VR) during hemodialysis can significantly impact psychological well-being and thus overall quality of life. The aim of the study was to assess the effects of VR therapy undertaken by hemodialysis (HD) patients on depression, anxiety, perceived self-efficacy and life satisfaction. Methods: Hemodialysis (HD) patients were recruited from the Dialysis Centre at St. Luke’s Hospital in Bolesławiec. Group I (experimental EG) included 16 HD patients, and Group II (control CG) included 22 HD patients (no VR session). The EG used VR for one month (maximum 14 sessions); the CG was the same group of patients assessed over a one-month period prior to the intervention. VR therapy took place at the beginning of dialysis, three times a week for one month. A personal questionnaire, the Hospital Anxiety and Depression Scale (HADS), the Perceived Stress Scale (PSS-10), the General Self-Efficacy Scale (GSES) and the Satisfaction with Life Scale (SWLS) were used. Results: In the group of patients undergoing VR therapy, a significant reduction in the level of anxiety, depression and stress was observed, as well as a significant increase in life satisfaction and self-efficacy levels compared to the control group. Conclusions: Undertaking VR therapy during dialysis for patients with ESRD is beneficial, improves mood, satisfaction with life, and perceived self-efficacy, and reduces anxiety, but multi-center studies are needed on a larger group of patients.

## Linked entities

- **Diseases:** end-stage renal disease (MONDO:0004375), depression (MONDO:0002050), anxiety (MONDO:0005618)

## Full-text entities

- **Diseases:** dementia (MESH:D003704), stroke (MESH:D020521), Fatigue (MESH:D005221), vertigo (MESH:D014717), Depression (MESH:D003866), renal disease (MESH:D007674), nausea (MESH:D009325), mood disorders (MESH:D019964), cognitive decline disorders (MESH:D003072), anxiety disorders (MESH:D001008), PTSD (MESH:D013313), labyrinth disorders (MESH:D007762), visual discomfort (MESH:D014786), SWLS (MESH:C538175), impaired consciousness (MESH:D003244), pain (MESH:D010146), anhedonia (MESH:D059445), somatic disorders (MESH:D013001), epilepsy (MESH:D004827), injury to (MESH:D014947), dizziness (MESH:D004244), Anxiety (MESH:D001007), ESRD (MESH:D007676), motion sickness (MESH:D009041), CKD (MESH:D012080), mental disorders (MESH:D001523), addictive (MESH:D019966)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12941698/full.md

---
Source: https://tomesphere.com/paper/PMC12941698